R2I D* SOFTWAY MEDICAL DEVELOPPEMENT
FranceEntry
2017
Hold
3yr
Exit
2020
Who owns R2I D* SOFTWAY MEDICAL DEVELOPPEMENT?
R2I D* SOFTWAY MEDICAL DEVELOPPEMENT was owned by Naxicap Partners through NIO I (2017 vintage) from 2017 to 2020, exited via MBO.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2020
More from NIO I
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
US
Track R2I D* Softway Medical Developpement
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy R2I D* Softway Medical Developpement?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on R2I D* Softway Medical Developpement.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue